HansBiomed Corporation (KOSDAQ: 042520)
South Korea
· Delayed Price · Currency is KRW 9,330.00
+160.00 (1.74%)
Oct 11, 2024, 9:00 AM KST
HansBiomed Ratios and Metrics
Market cap in millions KRW. Fiscal year is October - September.
Millions KRW. Fiscal year is Oct - Sep.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 10, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | 2018 - 2014 |
| Market Capitalization | 121,169 | 207,570 | 92,964 | 160,691 | 226,346 | 206,744 | Upgrade
|
| Market Cap Growth | -35.61% | 123.28% | -42.15% | -29.01% | 9.48% | -30.08% | Upgrade
|
| Enterprise Value | 147,163 | 241,607 | 132,643 | 187,080 | 248,070 | 217,340 | Upgrade
|
| Last Close Price | 9330.00 | 17930.00 | 9610.00 | 16050.00 | 22850.00 | 21850.00 | Upgrade
|
| PE Ratio | - | -8.34 | 53.28 | -8.78 | -12.64 | 21.59 | Upgrade
|
| PS Ratio | 1.46 | 2.66 | 1.25 | 2.72 | 2.83 | 3.09 | Upgrade
|
| PB Ratio | 1.64 | 4.16 | 1.96 | 3.38 | 3.27 | 2.46 | Upgrade
|
| P/FCF Ratio | -186.53 | -36.61 | -11.26 | -8.23 | -174.78 | -26.34 | Upgrade
|
| P/OCF Ratio | 97.28 | -55.60 | -21.77 | -10.97 | 39.36 | 26.80 | Upgrade
|
| EV/Sales Ratio | 1.82 | 3.10 | 1.78 | 3.17 | 3.10 | 3.24 | Upgrade
|
| EV/EBITDA Ratio | 109.73 | 231.57 | 21.54 | -12.48 | 1203.72 | 15.17 | Upgrade
|
| EV/EBIT Ratio | -75.61 | -58.15 | 105.60 | -9.46 | -72.81 | 17.29 | Upgrade
|
| EV/FCF Ratio | -180.97 | -42.61 | -16.07 | -9.58 | -191.56 | -27.69 | Upgrade
|
| Debt / Equity Ratio | 0.45 | 0.82 | 1.18 | 1.08 | 0.47 | 0.40 | Upgrade
|
| Debt / EBITDA Ratio | 11.25 | 39.43 | 9.08 | - | 159.38 | 2.35 | Upgrade
|
| Debt / FCF Ratio | -41.47 | -7.26 | -6.77 | -2.64 | -25.36 | -4.28 | Upgrade
|
| Asset Turnover | 0.64 | 0.61 | 0.57 | 0.45 | 0.60 | 0.59 | Upgrade
|
| Inventory Turnover | 1.12 | 1.20 | 1.26 | 1.64 | 2.28 | 1.95 | Upgrade
|
| Quick Ratio | 0.45 | 0.31 | 0.32 | 0.49 | 1.36 | 1.69 | Upgrade
|
| Current Ratio | 1.10 | 0.77 | 0.73 | 0.84 | 2.09 | 2.43 | Upgrade
|
| Return on Equity (ROE) | -15.81% | -49.47% | 10.36% | -37.86% | -23.70% | 12.38% | Upgrade
|
| Return on Assets (ROA) | -1.16% | -2.04% | 0.60% | -9.46% | -1.60% | 6.96% | Upgrade
|
| Return on Capital (ROIC) | -1.40% | -2.67% | 0.78% | -12.28% | -1.94% | 7.89% | Upgrade
|
| Earnings Yield | -8.07% | -11.10% | 6.61% | -11.38% | -7.88% | 4.81% | Upgrade
|
| FCF Yield | -0.67% | -2.73% | -8.88% | -12.16% | -0.57% | -3.80% | Upgrade
|
| Dividend Yield | 0.00% | - | - | - | - | 0.55% | Upgrade
|
| Payout Ratio | 0.00% | - | - | - | - | 9.87% | Upgrade
|
| Buyback Yield / Dilution | -22.39% | 18.41% | -31.21% | -1.48% | -0.37% | -1.98% | Upgrade
|
| Total Shareholder Return | -22.39% | 18.41% | -31.21% | -1.48% | -0.37% | -1.43% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.